Asthma Clinical Trials in Chicago

Showing 301-320 of 365 trials

Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

NCT00041561

The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.

Respiratory InsufficiencyAnoxemia

Mallinckrodt55 participantsStarted Jan 2002

Orange, California, United States • Stanford, California, United States • Denver, Colorado, United States +13 more locations

COMPLETEDPhase 42.2 miles

The Study of Soy Isoflavones in Asthma

NCT01052116

The trial is designed to study the effects of soy supplements on asthma control.

Asthma

American Lung Association Asthma Clinical Research Centers386 participantsStarted Mar 2010

Tucson, Arizona, United States • San Diego, California, United States • Denver, Colorado, United States +15 more locations

Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

The Study of Soy Isoflavones in Asthma

Asthma Trials in Other Cities

Study of Asthma and Nasal Steroids

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

The Role of Epigenetics in Inner City Asthma

Cross-sectional Study for Identification and Description of Severe Asthma Patients

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Improving Asthma Outcomes Through Spirometry Distance Learning

Other Conditions in Chicago